Tag:

GeoVax

Latest Headlines

Latest Headlines

Zika update: Vaccine race swells, PaxVax CEO on how to stop 'chasing epidemics'

February 10, 2016 | By
As the Zika virus continues to spread, more biotechs are announcing their Zika vaccine programs. Meriden, CT-based Protein Sciences, Atlanta-based GeoVax Labs and Redwood City, CA-based PaxVax are the latest. PaxVax plans to bring its candidate to animal trials during the first half of this year, CEO Nima Farzan told FierceVaccines.

GeoVax steps closer to HIV prevention

March 15, 2012 | By
To be really effective in people at a high risk of infection, an HIV vaccine needs to protect against not just one exposure but many, and recent research from GeoVax ($GOVX) might bring this ideal type of protection a step closer.
Related Tags

GeoVax Press Releases

  • GeoVax Receives "Allowed to Proceed" Notice for Testing Adjuvanted HIV Vaccine
  • GeoVax Labs Presents New Findings on Potential HIV Vaccine at 2012 Conference on Retroviruses and Opportunistic Infections (CROI)
  • GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
  • Expansion of HIV/AIDS Vaccine Program with National Institute of Allergy And Infectious Diseases Announced by GeoVax Labs
  • GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
Press Releases
  • Aratana Therapeutics Files for First European Approval
  • Ambry Genetics Unveils Its Super Lab, One of the Largest, Most State-of-the-Art Commercial Laboratories in the World
  • Johnson & Johnson Issues Call for Innovative Ideas to Reduce HIV Infections in Sub-Saharan Africa
  • PwC Launches New Offerings to Advance Innovation in Healthcare
  • Fifty-One Hospitals Pay United States More Than $23 Million to Resolve False Claims Act Allegations Related to Implantation of Cardiac Devices
  • More Press Releases
Sponsored Links